For the safety of our patients and staff, we now request that all visitors to MSK are fully vaccinated against COVID-19. Read the latest information for visitors.
New-generation Selective Inhibitors for Secondary Mutated Protein Kinases
Share
Print
Tri-Institutional Program: New-generation Selective Inhibitors for Secondary Mutated Protein Kinases.
Audience
This program is open to the research community.
Date & Time(s)
Location
This seminar will be conducted in ZRC 105 and by Zoom webinar.
Memorial Sloan Kettering Cancer Center
Zuckerman Research Center
417 East 68th Street
Room ZRC-105
New York, NY 10065